Stay updated on Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page
- CheckyesterdayChange DetectedA new publication about infections in daratumumab-treated newly diagnosed multiple myeloma was added to the Publications list, and a previously listed infection-related article was removed, updating the study's bibliography.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, indicating a minor metadata-only update. There were no visible changes to the page content or user-facing features.SummaryDifference0.0%

- Check30 days agoChange DetectedA recruitment status note 'No longer looking for participants' was added to the study page. The page also gained new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a UI header change for Intervention/Treatment and an updated revision tag (from v3.5.5 to v3.6.0).SummaryDifference0.2%

- Check37 days agoChange DetectedA new page revision entry (v3.5.5) was added and the previous revision (v3.5.4) was removed, indicating a minor update to the page's documentation.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page adds 'Multiple myeloma' and a 'related topics' section (including MedlinePlus Genetics) to broaden disease context, and includes a new MAIA-related publication citation in the Publications list.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision label was updated to v3.5.4, replacing the previous v3.5.3; this indicates a maintenance update rather than a change to study details.SummaryDifference0.0%

Stay in the know with updates to Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.